OWC Pharmaceutical Research Corp. (OTC: OWCP), developer of cannabinoid-based therapies targeting a variety of indications, recently announced that its wholly owned subsidiary, One World Cannabis Ltd., filed their sixth provisional patent application with the U.S. Patent and Trademark Office, relating to novel compositions and methods for administering pharmaceuticals.
“This provisional patent application protects key intellectual property relating to unique formulations and specific delivery systems for cannabinoid-based therapies,” said One World Cannabis CEO Mr. Ziv Turner. “We plan to continue to file additional patent applications covering our ideas and novel solutions to ultimately pave the way for our breakthrough technologies.”
The patent pertains to an emulsion comprised of enriched concentrations of tetrahydrocannabinol (“THC”), cannabidiol (“CBD”), or other cannabinoid derivatives that may be useful as a novel delivery mechanism for the treatment of various medical conditions. The company plans to leverage its intellectual property and collaboration agreements to conduct trials beginning in the second quarter of 2015.
Dr. Alan Shackelford leads the company’s scientific team, as a leading U.S. physician based in Colorado, specializing in the use of non-psychoactive cannabinoids in the treatment of various medical conditions. Dr. Yehuda Baruch heads the company’s Israel-based scientific team, as the former director and leader of the country’s medical cannabis program under the Ministry of Health.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.